Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.29

EVMN Q4 2024 Earnings — Evommune, Inc. Revenue & Financial Results | Market Cap Arena

EVMNEvommune, Inc.

$319M

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$19M

Net Income

-$18M

EPS (Diluted)

$-1.47

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$22M

Stock-Based Comp.

$448,000

Balance Sheet

Total Assets

$76M

Total Liabilities

$220M

Stockholders' Equity

$48M

Cash & Equivalents

$16M

← FY 2024 All Quarters Q1 2025 →